We continue to cooperate with the pharmaceutical company Pfizer: participation in a series of clinical trials of new IPs for the treatment of patients with ulcerative colitis has been proposed.
We continue to cooperate with the pharmaceutical company Pfizer: participation in a series of clinical trials of new IPs for the treatment of patients with ulcerative colitis has been proposed.
